Jorge Fernández-De-Cossio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jorge Fernández-De-Cossio has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Pagnani
Politecnico di Torino
2 shared publications - Guido Uguzzoni
Univ. Grenoble Alpes, CEA, Inserm, IRIG, UA13 BGE
2 shared publications - Jamilet Miranda
Bioinformatic Department, Center for Genetic Engineering and Biotechnology (CIGB), Havana 10600, Cuba
2 shared publications - Ricardo Bringas
Bioinformatic Department, Center for Genetic Engineering and Biotechnology (CIGB), Havana 10600, Cuba
2 shared publications - Ariadna Mendoza Cuevas
Ciências Exatas e Tecnológicas Identificação de Pigmentos e Perfil de Profundidade em Obras de Prof Archaeometry Laboratory University College San Geronimo de la Habana Cuba
1 shared publication Clément Nizak
Sorbonne University
1 shared publication
Latest Publications
- Open Access
Linking Brain and Behavior States in Zebrafish Larvae Locomotion using Hidden Markov Models
Understanding how collective neuronal activity in the brain orchestrates behavior is a central question in integrative neuroscience. Addressing this question requires models that can offer a unified interpretation of multimodal data. In this study, we jointly examine video-recordings of zebrafish larvae freely exploring their environment and calcium imaging of the Anterior Rhombencephalic Turning Region (ARTR) circuit, which is known to control swimming orientation, recorded in vivo under tethered conditions. We show that both behavioral and neural data can be accurately modeled using a Hidden Markov Model (HMM) with three hidden states. In the context of behavior, the hidden states correspond to leftward, rightward, and forward swimming. The HMM robustly captures the key statistical features of the swimming motion, including bout-type persistence and its dependence on bath temperature, while also revealing inter-individual phenotypic variability. For neural data, the three states correspond to left- and right-lateral activation of the ARTR circuit, known to govern the selection of left vs. right reorientation, and a balanced state, which likely corresponds to the behavioral forward state. To further unify the two analysis, we exploit the generative nature of the HMM, using the neural sequences to generate synthetic trajectories whose statistical properties are similar to the behavioral data. Overall, this work demonstrates how state-space models can be used to link neuronal and behavioral data, providing insights into the mechanisms of self-generated action.
Open AccessLinking Brain and Behavior States in Zebrafish Larvae Locomotion using Hidden Markov Models
Understanding how collective neuronal activity in the brain orchestrates behavior is a central question in integrative neuroscience. Addressing this question requires models that can offer a unified interpretation of multimodal data. In this study, we jointly examine video-recordings of zebrafish larvae freely exploring their environment and calcium imaging of the Anterior Rhombencephalic Turning Region (ARTR) circuit, which is known to control swimming orientation, recorded in vivo under tethered conditions. We show that both behavioral and neural data can be accurately modeled using a Hidden Markov Model (HMM) with three hidden states. In the context of behavior, the hidden states correspond to leftward, rightward, and forward swimming. The HMM robustly captures the key statistical features of the swimming motion, including bout-type persistence and its dependence on bath temperature, while also revealing inter-individual phenotypic variability. For neural data, the three states correspond to left- and right-lateral activation of the ARTR circuit, known to govern the selection of left vs. right reorientation, and a balanced state, which likely corresponds to the behavioral forward state. To further unify the two analysis, we exploit the generative nature of the HMM, using the neural sequences to generate synthetic trajectories whose statistical properties are similar to the behavioral data. Overall, this work demonstrates how state-space models can be used to link neuronal and behavioral data, providing insights into the mechanisms of self-generated action.
- Open Access
Unsupervised modeling of mutational landscapes of adeno-associated viruses viability
Adeno-associated viruses 2 (AAV2) are minute viruses renowned for their capacity to infect human cells and akin organisms. They have recently emerged as prominent candidates in the field of gene therapy, primarily attributed to their inherent non-pathogenic nature in humans and the safety associated with their manipulation. The efficacy of AAV2 as gene therapy vectors hinges on their ability to infiltrate host cells and subsequently replicate within them, a phenomenon reliant on their competence to construct a capsid capable of breaching the nucleus of the target cell. To enhance their infection potential, researchers have extensively scrutinized various combinatorial libraries by introducing mutations into the capsid, aiming to boost their effectiveness. The emergence of high-throughput experimental techniques, like Deep Mutational Scanning (DMS), has made it feasible to experimentally assess the fitness of these libraries for their intended purpose. Notably, machine learning is starting to demonstrate its potential in addressing predictions within the mutational landscape from sequence data. In this context, we introduce a biophysically-inspired model designed to predict the viability of genetic variants in DMS experiments. This model is tailored to a specific segment of the CAP region within AAV2’s capsid protein. To evaluate its effectiveness, we conduct model training with diverse datasets, each tailored to explore different aspects of the mutational landscape influenced by the selection process. Our assessment of the biophysical model centers on two primary objectives: (i) providing quantitative forecasts for the log-selectivity of variants and (ii) deploying it as a binary classifier to categorize sequences into viable and non-viable classes.
Open AccessUnsupervised modeling of mutational landscapes of adeno-associated viruses viability
Adeno-associated viruses 2 (AAV2) are minute viruses renowned for their capacity to infect human cells and akin organisms. They have recently emerged as prominent candidates in the field of gene therapy, primarily attributed to their inherent non-pathogenic nature in humans and the safety associated with their manipulation. The efficacy of AAV2 as gene therapy vectors hinges on their ability to infiltrate host cells and subsequently replicate within them, a phenomenon reliant on their competence to construct a capsid capable of breaching the nucleus of the target cell. To enhance their infection potential, researchers have extensively scrutinized various combinatorial libraries by introducing mutations into the capsid, aiming to boost their effectiveness. The emergence of high-throughput experimental techniques, like Deep Mutational Scanning (DMS), has made it feasible to experimentally assess the fitness of these libraries for their intended purpose. Notably, machine learning is starting to demonstrate its potential in addressing predictions within the mutational landscape from sequence data. In this context, we introduce a biophysically-inspired model designed to predict the viability of genetic variants in DMS experiments. This model is tailored to a specific segment of the CAP region within AAV2’s capsid protein. To evaluate its effectiveness, we conduct model training with diverse datasets, each tailored to explore different aspects of the mutational landscape influenced by the selection process. Our assessment of the biophysical model centers on two primary objectives: (i) providing quantitative forecasts for the log-selectivity of variants and (ii) deploying it as a binary classifier to categorize sequences into viable and non-viable classes.
- Open Access
Inference and design of antibody specificity: from experiments to models and back
Exquisite binding specificity is essential for many protein functions but is difficult to engineer. Many biotechnological or biomedical applications require the discrimination of very similar ligands, which poses the challenge of designing protein sequences with highly specific binding profiles. Current methods for generating specific binders rely on in vitro selection experiments, but these have limitations in terms of library size and control over specificity profiles. We present a multi-stage approach that overcomes these limitations by combining high-throughput sequencing of phage display experiments with machine learning and biophysical modeling. Our models predict the binding profiles of antibodies against multiple ligands and generate antibody sequences with desired specificity profiles. The approach involves the identification of different binding modes, each associated with a particular ligand against which the antibodies are either selected or not. We demonstrate that the model successfully disentangles these modes, even when they are associated with chemically very similar ligands. Additionally, we demonstrate and validate experimentally the computational design of antibodies with customized specificity profiles, either with specific high affinity for a particular target ligand, or with cross-specificity for multiple target ligands. Overall, our results showcase the potential of leveraging a biophysical model learned from selections against multiple ligands to design proteins with tailored specificity, with applications to protein engineering extending beyond the design of antibodies.
Open AccessInference and design of antibody specificity: from experiments to models and back
Exquisite binding specificity is essential for many protein functions but is difficult to engineer. Many biotechnological or biomedical applications require the discrimination of very similar ligands, which poses the challenge of designing protein sequences with highly specific binding profiles. Current methods for generating specific binders rely on in vitro selection experiments, but these have limitations in terms of library size and control over specificity profiles. We present a multi-stage approach that overcomes these limitations by combining high-throughput sequencing of phage display experiments with machine learning and biophysical modeling. Our models predict the binding profiles of antibodies against multiple ligands and generate antibody sequences with desired specificity profiles. The approach involves the identification of different binding modes, each associated with a particular ligand against which the antibodies are either selected or not. We demonstrate that the model successfully disentangles these modes, even when they are associated with chemically very similar ligands. Additionally, we demonstrate and validate experimentally the computational design of antibodies with customized specificity profiles, either with specific high affinity for a particular target ligand, or with cross-specificity for multiple target ligands. Overall, our results showcase the potential of leveraging a biophysical model learned from selections against multiple ligands to design proteins with tailored specificity, with applications to protein engineering extending beyond the design of antibodies.
- Open Access
- 21 August 2023
- Published by Universidade Estadual de Londrina in Semina: Ciências Exatas e Tecnológicas
- Vol. 44, e48506
Pigment Identification and Depth Profile in Pictorial Artworks by Non-Invasive Hybrid XRD-XRF Portable System
A non-invasive XRD-XRF portable system for Archaeometry based on Angle and Energy Dispersive XRD (Hybrid XRD) plus XRF has been previously proposed by the authors. It gathers an attractive compromise between analytical performance and measurement time, as well as a higher energy penetration with respect to conventional Angle Dispersive XRD (ADXRD). Penetration to inside layers, usually perceived as an inconvenient for non-invasive portable XRF or XRD analyzer, can instead be informative for the proposed hybrid XRD-XRF system to perform depth profiling analysis. This hybrid configuration harness from the redundancy of the data, in the sense that a single XRF or XRD specimen, taken at the same sample point, appears in multiple spectrograms to account for data counting statistics. On this work, the performance of the system on standard reference material, as well as the identification of pigments in the surface layer of paintings is evaluated. Specific Hybrid data processing was conceived to examine the layer structure of the painting, by distinguishing signal patterns of the exposed and the under layers. The system is ventured for the first time to the study of pictorial artworks in coffin and cartonnage samples from ancient Egyptian sarcophagi. Prussian blue pigment in a modeled painting is also discussed.
- 21 August 2023
- Published by Universidade Estadual de Londrina in Semina: Ciências Exatas e Tecnológicas
- Vol. 44, e48506
Open AccessPigment Identification and Depth Profile in Pictorial Artworks by Non-Invasive Hybrid XRD-XRF Portable System
A non-invasive XRD-XRF portable system for Archaeometry based on Angle and Energy Dispersive XRD (Hybrid XRD) plus XRF has been previously proposed by the authors. It gathers an attractive compromise between analytical performance and measurement time, as well as a higher energy penetration with respect to conventional Angle Dispersive XRD (ADXRD). Penetration to inside layers, usually perceived as an inconvenient for non-invasive portable XRF or XRD analyzer, can instead be informative for the proposed hybrid XRD-XRF system to perform depth profiling analysis. This hybrid configuration harness from the redundancy of the data, in the sense that a single XRF or XRD specimen, taken at the same sample point, appears in multiple spectrograms to account for data counting statistics. On this work, the performance of the system on standard reference material, as well as the identification of pigments in the surface layer of paintings is evaluated. Specific Hybrid data processing was conceived to examine the layer structure of the painting, by distinguishing signal patterns of the exposed and the under layers. The system is ventured for the first time to the study of pictorial artworks in coffin and cartonnage samples from ancient Egyptian sarcophagi. Prussian blue pigment in a modeled painting is also discussed.
- Open Access
HeberFERON distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG
Background: HeberFERON is a co-formulation of α2b and γ interferons, based on their synergism, that have shown its clinical superiority over individual interferons in basal cell carcinomas. In Glioblastoma (GBM), HeberFERON has shown promising preclinical and clinical results. This motivated us to design a microarray experiment aimed to identify the molecular mechanisms involved into the distinctive effect of HeberFERON compared with individual interferons. Methods: Transcriptional expression profiling including a control (untreated) and three groups receiving α2b-interferon, γ-interferon and HeberFERON was performed using an Illumina HT-12 microarray platform. Unsupervised methods for gene and sample grouping, identification of differentially expressed genes, functional enrichment and network analysis computational biology methods were applied to identify distinctive patterns of HeberFERON action. Validation of most distinctive genes was performed by qPCR. Cell Cycle analysis of cell treated by HeberFERON for 24h, 48h and 72h was carried out by flow cytometry. Results: The three treatments show different behavior based on the gene expression profiles. Enrichment analysis identified several Mitotic Cell Cycle related events, in particular from Prometaphase to Anaphase, that are exclusively targeted by HeberFERON. FOXM1 transcription factor network which is involved in several Cell Cycle phases and is highly expressed in GBMs is significantly down regulated by HeberFERON. Flow cytometry experiments corroborated the action of HeberFERON over Cell Cycle in a dose and time dependent manner with a clear cellular arrest since 24h post-treatment. Despite the fact that p53 was not down-regulated by HeberFERON several genes involved in its regulatory activity were functionally enriched. Network analysis also revealed a strong relation of p53 with genes targeted by HeberFERON. We propose a mechanistic model to explain HeberFERON distinctive action, based on the simultaneous activation of PKR and ATF3, p53 phosphorylation changes as well as its reduced MDM2 mediated ubiquitination and export from nucleus to cytoplasm. PLK1, AURKB, BIRC5 and CCNB1 genes, all regulated by FOXM1, also play central roles in this model. These and other interactions could explain a G2/M arrest and the effect of HeberFERON over the proliferation of U-87MG. Conclusions: We proposed molecular mechanisms underlying the distinctive behavior of HeberFERON compared to individual interferon treatments, where Cell Cycle related events showed the highest relevance.
Open AccessHeberFERON distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG
Background: HeberFERON is a co-formulation of α2b and γ interferons, based on their synergism, that have shown its clinical superiority over individual interferons in basal cell carcinomas. In Glioblastoma (GBM), HeberFERON has shown promising preclinical and clinical results. This motivated us to design a microarray experiment aimed to identify the molecular mechanisms involved into the distinctive effect of HeberFERON compared with individual interferons. Methods: Transcriptional expression profiling including a control (untreated) and three groups receiving α2b-interferon, γ-interferon and HeberFERON was performed using an Illumina HT-12 microarray platform. Unsupervised methods for gene and sample grouping, identification of differentially expressed genes, functional enrichment and network analysis computational biology methods were applied to identify distinctive patterns of HeberFERON action. Validation of most distinctive genes was performed by qPCR. Cell Cycle analysis of cell treated by HeberFERON for 24h, 48h and 72h was carried out by flow cytometry. Results: The three treatments show different behavior based on the gene expression profiles. Enrichment analysis identified several Mitotic Cell Cycle related events, in particular from Prometaphase to Anaphase, that are exclusively targeted by HeberFERON. FOXM1 transcription factor network which is involved in several Cell Cycle phases and is highly expressed in GBMs is significantly down regulated by HeberFERON. Flow cytometry experiments corroborated the action of HeberFERON over Cell Cycle in a dose and time dependent manner with a clear cellular arrest since 24h post-treatment. Despite the fact that p53 was not down-regulated by HeberFERON several genes involved in its regulatory activity were functionally enriched. Network analysis also revealed a strong relation of p53 with genes targeted by HeberFERON. We propose a mechanistic model to explain HeberFERON distinctive action, based on the simultaneous activation of PKR and ATF3, p53 phosphorylation changes as well as its reduced MDM2 mediated ubiquitination and export from nucleus to cytoplasm. PLK1, AURKB, BIRC5 and CCNB1 genes, all regulated by FOXM1, also play central roles in this model. These and other interactions could explain a G2/M arrest and the effect of HeberFERON over the proliferation of U-87MG. Conclusions: We proposed molecular mechanisms underlying the distinctive behavior of HeberFERON compared to individual interferon treatments, where Cell Cycle related events showed the highest relevance.
- Open Access
CIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approach
Drug repositioning became the first choice for treating Covid-19 patients due to the urgent need to deal with the pandemic. Similarities in the hijacking mechanisms used by SARS-CoV-2 and several type of cancer, suggest the repurposing of cancer drugs to treat Covid-19. CK2 kinase antagonists have been proposed for the treatment of cancer. A recent study in cells infected with SARS-CoV-2 virus found a significant CK2 kinase activity, and the use of a CK2 inhibitor showed antiviral responses. CIGB-300, originally designed as an anticancer peptide, is an antagonist of CK2 kinase activity that binds to CK2 phospho-acceptor sites. Recent preliminary results show an antiviral activity of CIGB-300 versus a surrogate model of coronavirus. Here we present a computational biology study that provides evidences at the molecular level of how CIGB-300 might interfere with SARS-CoV-2 life cycle inside infected human cells. First, from SARS-CoV studies, we infer the potential incidence of CIGB-300 in SARS-CoV-2 interference on immune response. Next, from the analysis of multiple Omics data, we propose the action of CIGB-300 since early stage of viral infections perturbing the virus hijacking of RNA splicing machinery. It was also predicted the interference of CIGB-300 in virus-host interactions responsible for the high infectivity and the particular immune response to SARS-CoV-2 infection. Further, we provide evidences of CIGB-300 attenuation of phenotypes related to muscle, bleeding, coagulation and respiratory disorders.
Open AccessCIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approach
Drug repositioning became the first choice for treating Covid-19 patients due to the urgent need to deal with the pandemic. Similarities in the hijacking mechanisms used by SARS-CoV-2 and several type of cancer, suggest the repurposing of cancer drugs to treat Covid-19. CK2 kinase antagonists have been proposed for the treatment of cancer. A recent study in cells infected with SARS-CoV-2 virus found a significant CK2 kinase activity, and the use of a CK2 inhibitor showed antiviral responses. CIGB-300, originally designed as an anticancer peptide, is an antagonist of CK2 kinase activity that binds to CK2 phospho-acceptor sites. Recent preliminary results show an antiviral activity of CIGB-300 versus a surrogate model of coronavirus. Here we present a computational biology study that provides evidences at the molecular level of how CIGB-300 might interfere with SARS-CoV-2 life cycle inside infected human cells. First, from SARS-CoV studies, we infer the potential incidence of CIGB-300 in SARS-CoV-2 interference on immune response. Next, from the analysis of multiple Omics data, we propose the action of CIGB-300 since early stage of viral infections perturbing the virus hijacking of RNA splicing machinery. It was also predicted the interference of CIGB-300 in virus-host interactions responsible for the high infectivity and the particular immune response to SARS-CoV-2 infection. Further, we provide evidences of CIGB-300 attenuation of phenotypes related to muscle, bleeding, coagulation and respiratory disorders.
- 18 March 2011
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 83 (8) , 2890-2896
Mass Spectrum Patterns of 18O-Tagged Peptides Labeled by Enzyme-Catalyzed Oxygen Exchange
18O-labeling of peptides is a technique widely and routinely applied in the protein chemistry laboratories. The rate of 18O incorporation at the carboxyl terminus of peptides via enzyme-catalyzed oxygen exchange fluctuates from peptide to peptide. This fluctuation is mostly attributed to enzyme−substrate different affinity. The final distributions of the 18O0-, 18O1-, and 18O2-tagged peptides remain unpredictable though usually constrained to binomial proportions. It is proved here that this constraint can sometimes be a poor model. A more general model is then derived which predicts linear paths for digestion in H218O-enriched water while confining binomial proportions to postdigestion labeling. Both subderived models are simple in structure and relevant for the current software development in the analysis of quantitative shotgun proteomics data. Accuracy and time dependency are examined and compared with actual labeled-digest data.
- 18 March 2011
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 83 (8) , 2890-2896
Mass Spectrum Patterns of 18O-Tagged Peptides Labeled by Enzyme-Catalyzed Oxygen Exchange
18O-labeling of peptides is a technique widely and routinely applied in the protein chemistry laboratories. The rate of 18O incorporation at the carboxyl terminus of peptides via enzyme-catalyzed oxygen exchange fluctuates from peptide to peptide. This fluctuation is mostly attributed to enzyme−substrate different affinity. The final distributions of the 18O0-, 18O1-, and 18O2-tagged peptides remain unpredictable though usually constrained to binomial proportions. It is proved here that this constraint can sometimes be a poor model. A more general model is then derived which predicts linear paths for digestion in H218O-enriched water while confining binomial proportions to postdigestion labeling. Both subderived models are simple in structure and relevant for the current software development in the analysis of quantitative shotgun proteomics data. Accuracy and time dependency are examined and compared with actual labeled-digest data.